Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-08T08:17:28.833Z Has data issue: false hasContentIssue false
  • English
  • Français

Congenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency

Published online by Cambridge University Press:  30 April 2007

João Gonçalves ,
Ana Friães  and
Luís Moura
João Gonçalves*
Affiliation:
Centro de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa, Portugal.
Ana Friães
Affiliation:
Previous address: Centro de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa, Portugal. Current address: Instituto de Microbiologia, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Luís Moura
Affiliation:
Hospital Pediátrico de Coimbra, Unidade de Endocrinologia Pediátrica, Coimbra, Portugal.
*
*Corresponding author: João Gonçalves, Sector da Patologia do Desenvolvimento Sexual, Centro de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Av. Padre Cruz, 1649-016 Lisboa, Portugal. Tel: +351 217519320; Fax: +351 217526410; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by defects in one of several steroidogenic enzymes involved in the synthesis of cortisol from cholesterol in the adrenal glands. More than 90% of cases are caused by 21-hydroxylase deficiency, and the severity of the resulting clinical symptoms varies according to the level of 21-hydroxylase activity. 21-Hydroxylase deficiency is usually caused by mutations in the CYP21A2 gene, which is located on the RCCX module, a chromosomal region highly prone to genetic recombination events that can result in a wide variety of complex rearrangements, such as gene duplications, gross deletions and gene conversions of variable extensions. Molecular genotyping of CYP21A2 and the RCCX module has proved useful for a more accurate diagnosis of the disease, and prenatal diagnosis. This article summarises the clinical features of 21-hydroxylase deficiency, explains current understanding of the disease at the molecular level, and highlights recent developments, particularly in diagnosis.

Type
Research Article
Information
Expert Reviews in Molecular Medicine , Volume 9 , Issue 11 , April 2007 , pp. 1 - 23
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

1Itoi, K., Seasholtz, A.F. and Watson, S.J. (1998) Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons. Endocr J 45, 13-33CrossRefGoogle ScholarPubMed
2Waterman, M.R. and Bischof, L.J. (1997) Cytochromes P450 12: diversity of ACTH (cAMP)-dependent transcription of bovine steroid hydroxylase genes. Faseb J 11, 419-427CrossRefGoogle ScholarPubMed
3Williams, J.S. and Williams, G.H. (2003) 50th anniversary of aldosterone. J Clin Endocrinol Metab 88, 2364-2372CrossRefGoogle ScholarPubMed
4Migeon, C.J. and Donohoue, P.A. (1994) Adrenal disorders. In Wilkins: The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence (4th edn), (Kappy, M.S., Blizzard, R.M. and Migeon, C.J., eds), pp. 717-856, Charles C. Thomas, SpringfieldGoogle Scholar
5Goto, M. et al. (2006) In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest 116, 953-960CrossRefGoogle ScholarPubMed
6White, P.C. (2006) Ontogeny of adrenal steroid biosynthesis: why girls will be girls. J Clin Invest 116, 872-874Google Scholar
7Donohoue, P.A., Parker, K. and Migeon, C.J. (1995) Congenital adrenal hyperplasia. In The Metabolic and Molecular Bases of Inherited Disease (Scriver, C.R. et al. , eds), pp. 2929-2966, McGraw Hill, New YorkGoogle Scholar
8Moore, K.L. and Persaud, T.V.N. (1993) The urogenital system. In The Developing Human - Clinically Oriented Embryology (5th edn), pp. 265-303, W.B. Saunders, PhiladelphiaGoogle Scholar
9Fluck, C.E. et al. (2004) Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36, 228-230Google Scholar
10Fluck, C.E. and Miller, W.L. (2006) P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia. Curr Opin Pediatr 18, 435-441Google Scholar
11Fukami, M. et al. (2005) Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab 90, 414-426CrossRefGoogle ScholarPubMed
12Huang, N. et al. (2005) Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 76, 729-749CrossRefGoogle ScholarPubMed
13White, P.C. and Speiser, P.W. (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21, 245-291Google ScholarPubMed
14Kovacs, J. et al. (2001) Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J Clin Endocrinol Metab 86, 2958-2964Google Scholar
15Brinkmann, A.O. (2001) Molecular basis of androgen insensitivity. Mol Cell Endocrinol 179, 105-109CrossRefGoogle ScholarPubMed
16New, M.I. (2006) Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 91, 4205-4214(Erratum in: J Clin Endocrinol Metab 2007, 92, 142)CrossRefGoogle ScholarPubMed
17Pang, S.Y. et al. (1988) Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81, 866-874Google Scholar
18Therrell, B.L. Jr. et al. (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101, 583-590CrossRefGoogle ScholarPubMed
19van der Kamp, H.J. and Wit, J.M. (2004) Neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol 151 (Suppl 3), U71-75Google Scholar
20Speiser, P.W. et al. (1985) High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37, 650-667Google ScholarPubMed
21White, P.C. et al. (1985) Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci U S A 82, 1089-1093CrossRefGoogle ScholarPubMed
22Higashi, Y. et al. (1986) Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci U S A 83, 2841-2845CrossRefGoogle Scholar
23Lee, H.H., Lee, Y.J. and Lin, C.Y. (2004) PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module. Genomics 83, 944-950Google Scholar
24Blanchong, C.A. et al. (2000) Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med 191, 2183-2196CrossRefGoogle ScholarPubMed
25White, P.C., New, M.I. and Dupont, B. (1984) HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci U S A 81, 7505-7509Google Scholar
26Werkmeister, J.W. et al. (1986) Frequent deletion and duplication of the steroid 21-hydroxylase genes. Am J Hum Genet 39, 461-469Google Scholar
27Lee, H.H. (2005) Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module. Mol Genet Metab 84, 4-8CrossRefGoogle ScholarPubMed
28Chang, S.F. and Chung, B.C. (1995) Difference in transcriptional activity of two homologous CYP21A genes. Mol Endocrinol 9, 1330-1336Google Scholar
29Friaes, A. et al. (2006) CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions. Mol Genet Metab 88, 58-65Google Scholar
30Koppens, P.F., Hoogenboezem, T. and Degenhart, H.J. (2002) Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes. Hum Genet 111, 405-410Google Scholar
31Haglund-Stengler, B. et al. (1991) Haplotypes of the steroid 21-hydroxylase gene region encoding mild steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A 88, 8352-8356CrossRefGoogle ScholarPubMed
32Wedell, A., Stengler, B. and Luthman, H. (1994) Characterization of mutations on the rare duplicated C4/CYP21 haplotype in steroid 21-hydroxylase deficiency. Hum Genet 94, 50-54Google Scholar
33Levo, A. and Partanen, J. (1997) Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles. Hum Genet 99, 488-497CrossRefGoogle ScholarPubMed
34Dolzan, V. et al. (1999) Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status. Eur J Endocrinol 141, 132-139CrossRefGoogle ScholarPubMed
35Kharrat, M. et al. (2004) Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J Clin Endocrinol Metab 89, 368-374Google Scholar
36Owerbach, D. et al. (1992) Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency. Mol Endocrinol 6, 1211-1215Google ScholarPubMed
37Higashi, Y. et al. (1988) Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. Proc Natl Acad Sci U S A 85, 7486-7490CrossRefGoogle ScholarPubMed
38Lee, H.H. and Chang, S.F. (2001) Multiple transcripts of the CYP21 gene are generated by the mutation of the splicing donor site in intron 2 from GT to AT in 21-hydroxylase deficiency. J Endocrinol 171, 397-402Google Scholar
39Honour, J.W. and Rumsby, G. (1993) Problems in diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 45, 69-74CrossRefGoogle ScholarPubMed
40Lee, H.H. et al. (2000) Analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency. Clin Chem 46, 606-611CrossRefGoogle ScholarPubMed
41Owerbach, D., Crawford, Y.M. and Draznin, M.B. (1990) Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification. Mol Endocrinol 4, 125-131CrossRefGoogle Scholar
42Wedell, A. and Luthman, H. (1993) Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Hum Mol Genet 2, 499-504CrossRefGoogle ScholarPubMed
43Krone, N. et al. (2002) Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia. Clin Chem 48, 818-825CrossRefGoogle ScholarPubMed
44Keen-Kim, D. et al. (2005) Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency). J Mol Diagn 7, 236-246CrossRefGoogle ScholarPubMed
45Orita, M. et al. (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 86, 2766-2770CrossRefGoogle ScholarPubMed
46Abrams, E.S., Murdaugh, S.E. and Lerman, L.S. (1990) Comprehensive detection of single base changes in human genomic DNA using denaturing gradient gel electrophoresis and a GC clamp. Genomics 7, 463-475Google Scholar
47Bobba, A. et al. (1997) Characterisation of CAH alleles with non-radioactive DNA single strand conformation polymorphism analysis of the CYP21 gene. J Med Genet 34, 223-228CrossRefGoogle ScholarPubMed
48Morel, Y. and Miller, W.L. (1991) Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 20, 1-68Google ScholarPubMed
49Lee, H.H. et al. (2003) Duplication of 111 bases in exon 1 of the CYP21 gene is combined with deletion of CYP21P-C4B genes in steroid 21-hydroxylase deficiency. Mol Genet Metab 79, 214-220Google Scholar
50Olney, R.C. et al. (2002) Using real-time, quantitative PCR for rapid genotyping of the steroid 21-hydroxylase gene in a north Florida population. J Clin Endocrinol Metab 87, 735-741Google Scholar
51Tukel, T. et al. (2003) A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency. J Clin Endocrinol Metab 88, 5893-5897Google Scholar
52Krone, N. et al. (2005) The residue E351 is essential for the activity of human 21-hydroxylase: evidence from a naturally occurring novel point mutation compared with artificial mutants generated by single amino acid substitutions. J Mol Med 83, 561-568Google Scholar
53Grischuk, Y. et al. (2006) Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis. J Clin Endocrinol Metab 91, 4976-4980CrossRefGoogle ScholarPubMed
54Barbaro, M. et al. (2006) Functional studies of two novel and two rare mutations in the 21-hydroxylase gene. J Mol Med 84, 521-528CrossRefGoogle ScholarPubMed
55Kotaska, K., Lisa, L. and Prusa, R. (2003) Common CYP21 gene mutations in Czech patients and statistical analysis of worldwide mutation distribution. Cent Eur J Public Health 11, 124-128Google Scholar
56Ordonez-Sanchez, M.L. et al. (1998) Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: identification of possible new mutations and high prevalence of apparent germ-line mutations. Hum Genet 102, 170-177Google Scholar
57Ko, T.M. et al. (1998) Congenital adrenal hyperplasia. Molecular characterization. J Reprod Med 43, 379-386Google Scholar
58Vakili, R. et al. (2005) Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran. Horm Res 63, 119-124Google Scholar
59Dolzan, V. et al. (2005) Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol 153, 99-106CrossRefGoogle ScholarPubMed
60Asanuma, A. et al. (1999) Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency. J Hum Genet 44, 312-317Google Scholar
61Mathur, R. et al. (2001) Molecular characterization of mutations in Indian children with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 14, 27-35Google Scholar
62Stikkelbroeck, N.M. et al. (2003) CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab 88, 3852-3859CrossRefGoogle Scholar
63Day, D.J. et al. (1995) Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction. Genomics 29, 152-162CrossRefGoogle Scholar
64Day, D.J. et al. (1996) Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet 5, 2039-2048CrossRefGoogle Scholar
65Van de Velde, H. et al. (1999) Fluorescent PCR and automated fragment analysis in preimplantation genetic diagnosis for 21-hydroxylase deficiency in congenital adrenal hyperplasia. Mol Hum Reprod 5, 691-696CrossRefGoogle Scholar
66Lajic, S. et al. (2004) Prenatal treatment of congenital adrenal hyperplasia. Eur J Endocrinol 151 (Suppl 3), U63-69CrossRefGoogle ScholarPubMed
67Avent, N.D. and Chitty, L.S. (2006) Non-invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound. Prenat Diagn 26, 598-603CrossRefGoogle ScholarPubMed
68Bartha, J.L., Finning, K. and Soothill, P.W. (2003) Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency. Obstet Gynecol 101, 1135-1136Google Scholar
69Hyett, J.A. et al. (2005) Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 25, 1111-1116CrossRefGoogle ScholarPubMed
70Sermon, K. (2002) Current concepts in preimplantation genetic diagnosis (PGD): a molecular biologist's view. Hum Reprod Update 8, 11-20Google Scholar
71Renwick, P. and Ogilvie, C.M. (2007) Preimplantation genetic diagnosis for monogenic diseases: overview and emerging issues. Expert Rev Mol Diagn 7, 33-43Google Scholar
72Thornhill, A.R. et al. (2005) ESHRE PGD Consortium ‘Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)’. Hum Reprod 20, 35-48CrossRefGoogle ScholarPubMed
73Mao, R. et al. (2005) The implication of de novo 21-hydroxylase mutation in clinical and prenatal molecular diagnoses. Genet Test 9, 121-125CrossRefGoogle ScholarPubMed
74Hsueh, A.J., Bouchard, P. and Ben-Shlomo, I. (2005) Hormonology: a genomic perspective on hormonal research. J Endocrinol 187, 333-338Google Scholar
75Merke, D.P. et al. (2002) NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med 136, 320-334CrossRefGoogle Scholar
76Yanase, T. et al. (2006) Differentiation and regeneration of adrenal tissues: an initial step toward regeneration therapy for steroid insufficiency. Endocr J 53, 449-459Google Scholar
77Cuellar, T.L. and McManus, M.T. (2005) MicroRNAs and endocrine biology. J Endocrinol 187, 327-332CrossRefGoogle ScholarPubMed
78Bose, H.S. et al. (1996) The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N Engl J Med 335, 1870-1878Google Scholar
79Bose, H.S., Pescovitz, O.H. and Miller, W.L. (1997) Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab 82, 1511-1515Google Scholar
80Fujieda, K. et al. (1997) Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest 99, 1265-1271Google Scholar
81Lin, D. et al. (1995) Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267, 1828-1831CrossRefGoogle ScholarPubMed
82Nakae, J. et al. (1997) Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet 6, 571-576CrossRefGoogle ScholarPubMed
83Fluck, C.E. et al. (2005) A novel mutation L260P of the steroidogenic acute regulatory protein gene in three unrelated patients of Swiss ancestry with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab 90, 5304-5308Google Scholar
84Chen, X. et al. (2005) A genetic isolate of congenital lipoid adrenal hyperplasia with atypical clinical findings. J Clin Endocrinol Metab 90, 835-840CrossRefGoogle ScholarPubMed
85Baker, B.Y. et al. (2006) Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. J Clin Endocrinol Metab 91, 4781-4785Google Scholar
86Yoo, H.W. and Kim, G.H. (1998) Molecular and clinical characterization of Korean patients with congenital lipoid adrenal hyperplasia. J Pediatr Endocrinol Metab 11, 707-711CrossRefGoogle ScholarPubMed
87Stocco, D.M. (2002) Clinical disorders associated with abnormal cholesterol transport: mutations in the steroidogenic acute regulatory protein. Mol Cell Endocrinol 191, 19-25Google Scholar
88Miller, W.L. (1987) Structure of genes encoding steroidogenic enzymes. J Steroid Biochem 27, 759-766Google Scholar
89Miller, W.L. (1998) Why nobody has P450scc (20,22 desmoslase) deficiency. J Clin Endocrinol Metab 83, 1399-1400Google Scholar
90Tajima, T. et al. (2001) Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 86, 3820-3825CrossRefGoogle Scholar
91Katsumata, N. et al. (2002) Compound heterozygous mutations in the cholesterol side-chain cleavage enzyme gene (CYP11A) cause congenital adrenal insufficiency in humans. J Clin Endocrinol Metab 87, 3808-3813CrossRefGoogle ScholarPubMed
92Hiort, O. et al. (2005) Homozygous disruption of P450 side-chain cleavage (CYP11A1) is associated with prematurity, complete 46,XY sex reversal, and severe adrenal failure. J Clin Endocrinol Metab 90, 538-541Google Scholar
93al Kandari, H. et al. (2006) Homozygous mutation of P450 side-chain cleavage enzyme gene (CYP11A1) in 46,XY patient with adrenal insufficiency, complete sex reversal, and agenesis of corpus callosum. J Clin Endocrinol Metab 91, 2821-2826CrossRefGoogle Scholar
94Berube, D. et al. (1989) Assignment of the human 3 beta-hydroxysteroid dehydrogenase gene (HSDB3) to the p13 band of chromosome 1. Cytogenet Cell Genet 52, 199-200Google Scholar
95Rheaume, E. et al. (1991) Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. Mol Endocrinol 5, 1147-1157Google Scholar
96Gingras, S. et al. (1999) Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13. Mol Endocrinol 13, 66-81Google Scholar
97Simard, J. et al. (2005) Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr Rev 26, 525-582CrossRefGoogle ScholarPubMed
98Lutfallah, C. et al. (2002) Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 87, 2611-2622Google ScholarPubMed
99Johannsen, T.H. et al. (2005) Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 90, 2076-2080Google Scholar
100Mermejo, L.M. et al. (2005) Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping. J Clin Endocrinol Metab 90, 1287-1293CrossRefGoogle ScholarPubMed
101Mendonca, B.B. et al. (1987) Male pseudohermaphroditism due to nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency: gender role change and absence of gynecomastia at puberty. J Steroid Biochem 28, 669-675CrossRefGoogle Scholar
102Mendonca, B.B. et al. (1994) Mutation in 3beta-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females. J Mol Endocrinol 12, 119-122CrossRefGoogle ScholarPubMed
103Moisan, A.M. et al. (1999) New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. J Clin Endocrinol Metab 84, 4410-4425Google Scholar
104Zhang, L. et al. (2000) Characterization of two novel homozygous missense mutations involving codon 6 and 259 of type II 3beta-hydroxysteroid dehydrogenase (3betaHSD) gene causing, respectively, nonsalt-wasting and salt-wasting 3betaHSD deficiency disorder. J Clin Endocrinol Metab 85, 1678-1685Google ScholarPubMed
105Marui, S. et al. (2000) Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls. Clin Endocrinol 52, 67-75CrossRefGoogle ScholarPubMed
106Sparkes, R.S., Klisak, I. and Miller, W.L. (1991) Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin to 11q22; adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25. DNA Cell Biol 10, 359-365Google Scholar
107Nakajin, S. et al. (1981) Microsomal cytochrome P-450 from neonatal pig testis: two enzymatic activities (17 alpha-hydroxylase and c17,20-lyase) associated with one protein. Biochemistry 20, 4037-4042CrossRefGoogle ScholarPubMed
108Lee-Robichaud, P. et al. (1995) Modulation of the activity of human 17 alpha-hydroxylase-17,20-lyase (CYP17) by cytochrome b5: endocrinological and mechanistic implications. Biochem J 308, 901-908CrossRefGoogle ScholarPubMed
109Fluck, C.E., Miller, W.L. and Auchus, R.J. (2003) The 17,20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway. J Clin Endocrinol Metab 88, 3762-3766CrossRefGoogle ScholarPubMed
110Yanase, T. (1995) 17 alpha-Hydroxylase/17,20-lyase defects. J Steroid Biochem Mol Biol 53, 153-157Google Scholar
111Geller, D.H. et al. (1997) The genetic and functional basis of isolated 17,20-lyase deficiency. Nat Genet 17, 201-205Google Scholar
112Van Den Akker, E.L. et al. (2002) Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency. J Clin Endocrinol Metab 87, 5714-5721Google Scholar
113Sherbet, D.P. et al. (2003) CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding. J Biol Chem 278, 48563-48569Google Scholar
114ten Kate-Booij, M.J. et al. (2004) Deficiency of 17,20-lyase causing giant ovarian cysts in a girl and a female phenotype in her 46,XY sister: case report. Hum Reprod 19, 456-459CrossRefGoogle Scholar
115Martin, R.M. et al. (2003) P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab 88, 5739-5746CrossRefGoogle ScholarPubMed
116Costa-Santos, M., Kater, C.E. and Auchus, R.J. (2004) Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab 89, 49-60CrossRefGoogle ScholarPubMed
117Patocs, A. et al. (2005) Novel mutation of the CYP17 gene in two unrelated patients with combined 17alpha-hydroxylase/17,20-lyase deficiency: demonstration of absent enzyme activity by expressing the mutant CYP17 gene and by three-dimensional modeling. J Steroid Biochem Mol Biol 97, 257-265Google Scholar
118Mussig, K. et al. (2005) 17alpha-hydroxylase/17,20-lyase deficiency caused by a novel homozygous mutation (Y27Stop) in the cytochrome CYP17 gene. J Clin Endocrinol Metab 90, 4362-4365Google Scholar
119Brooke, A.M. et al. (2006) A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiency. J Clin Endocrinol Metab 91, 2428-2431CrossRefGoogle Scholar
120Lee, L.S. et al. (2006) A novel compound heterozygous mutation of K494_V495 deletion plus R496L and D487_F489 deletion in extreme C-terminus of cytochrome P450c17 causes 17alpha-hydroxylase deficiency. Mol Cell Endocrinol 249, 16-20Google Scholar
121Ergun-Longmire, B. et al. (2006) Two novel mutations found in a patient with 17alpha-hydroxylase enzyme deficiency. J Clin Endocrinol Metab 91, 4179-4182CrossRefGoogle Scholar
122Auchus, R.J. (2001) The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am 30, 101-119CrossRefGoogle ScholarPubMed
123White, P.C., Curnow, K.M. and Pascoe, L. (1994) Disorders of steroid 11 beta-hydroxylase isozymes. Endocr Rev 15, 421-438Google Scholar
124Rosler, A., Leiberman, E. and Cohen, T. (1992) High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. Am J Med Genet 42, 827-834Google Scholar
125Paperna, T. et al. (2005) Mutations in CYP11B1 and congenital adrenal hyperplasia in Moroccan Jews. J Clin Endocrinol Metab 90, 5463-5465Google Scholar
126Chua, S.C. et al. (1987) Cloning of cDNA encoding steroid 11beta-hydroxylase (P450c11). Proc Natl Acad Sci U S A 84, 7193-7197CrossRefGoogle ScholarPubMed
127Tonetto-Fernandes, V. et al. (2006) Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab 91, 2179-2184Google Scholar
128Zhu, Y.S. et al. (2003) Mutations in CYP11B1 gene: phenotype-genotype correlations. Am J Med Genet A 122, 193-200Google Scholar
129Grigorescu Sido, A. et al. (2005) 21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 90, 5769-5773Google Scholar
130Lee, H.H. et al. (2005) Novel missense mutations, GCC [Ala306]- > GTC [Val] and ACG [Thr318]- > CCG [Pro], in the CYP11B1 gene cause steroid 11beta-hydroxylase deficiency in the Chinese. Clin Endocrinol 62, 418-422Google Scholar
131Krone, N. et al. (2005) Congenital adrenal hyperplasia due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three-base pair deletion in the CYP11B1 gene. J Clin Endocrinol Metab 90, 3724-3730CrossRefGoogle Scholar
132Krone, N. et al. (2006) Analyzing the functional and structural consequences of two point mutations (P94L and A368D) in the CYP11B1 gene causing congenital adrenal hyperplasia resulting from 11-hydroxylase deficiency. J Clin Endocrinol Metab 91, 2682-2688Google Scholar
133Joehrer, K. et al. (1997) CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Hum Mol Genet 6, 1829-1834Google Scholar
134Clark, P.A. (2000) Nonclassic 11beta-hydroxylase deficiency: report of two patients and review. J Pediatr Endocrinol Metab 13, 105-109Google Scholar
135Arlt, W. et al. (2004) Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363, 2128-2135Google Scholar
136Pandey, A.V. et al. (2004) P450 oxidoreductase deficiency: a new disorder of steroidogenesis affecting all microsomal P450 enzymes. Endocr Res 30, 881-888Google Scholar
137Adachi, M. et al. (2004) Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome. Am J Med Genet A 128, 333-339Google Scholar
138Williamson, L. et al. (2006) Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency. Am J Med Genet A 140, 1797-1803CrossRefGoogle Scholar
139New, M.I. (2006) Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 91, 4205-4214CrossRefGoogle ScholarPubMed
140Miller, W.L. (2007) StAR search – what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import. Mol Endocrinol 21, 589-601CrossRefGoogle ScholarPubMed

Further reading, resources and contacts

CYP21A2 allele nomenclature, mutations and associated phenotypes are summarised at:

http://www.cypalleles.ki.se/cyp21.htm Google Scholar
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM Google Scholar
http://caresfoundation.org/links.htmlGoogle Scholar
http://www.genetests.org/ Google Scholar
http://www.hopkinschildrens.org/specialties/categorypages/cah Google Scholar
http://www.cahclan.org Google Scholar
http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CYP21A2 Google Scholar
http://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasiaGoogle Scholar